BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Effects of dietary <i>Bacillus amyloliquefaciens</i> supplementation on growth performance, intestinal morphology, inflammatory response, and microbiota of intra-uterine growth retarded weanling piglets. ✅
Go to Publication ✅
Journal of animal science and biotechnology (J Anim Sci Biotechnol ) Vol: 9 Issue Pages: 22 Pub: 2018 Epub: 2018 Mar 13 Authors Li Y , Zhang H , Su W , Ying Z , Chen Y , Zhang L , Lu Z , Wang T , |
|
|
Effects of Bacillus amyloliquefaciens Instead of Antibiotics on Growth Performance, Intestinal Health, and Intestinal Microbiota of Broilers. ✅
Go to Publication ✅
Frontiers in veterinary science (Front Vet Sci ) Vol: 8 Issue Pages: 679368 Pub: 2021 Epub: 2021 Jun 4 Authors Wang B , Zhou Y , Tang L , Zeng Z , Gong L , Wu Y , Li WF , |
|
|
Effects of Bacillus amyloliquefaciens Instead of Antibiotics on Growth Performance, Intestinal Health, and Intestinal Microbiota of Broilers. ✅
Go to Publication ✅
Frontiers in veterinary science (Front Vet Sci ) Vol: 8 Issue Pages: 679368 Pub: 2021 Epub: 2021 Jun 4 Authors Wang B , Zhou Y , Tang L , Zeng Z , Gong L , Wu Y , Li WF , |
|
|
Effects of Bacillus amyloliquefaciens Instead of Antibiotics on Growth Performance, Intestinal Health, and Intestinal Microbiota of Broilers. ✅
Go to Publication ✅
Frontiers in veterinary science (Front Vet Sci ) Vol: 8 Issue Pages: 679368 Pub: 2021 Epub: 2021 Jun 4 Authors Wang B , Zhou Y , Tang L , Zeng Z , Gong L , Wu Y , Li WF , |
|
|
Bacillus amyloliquefaciens 40 regulates piglet performance, antioxidant capacity, immune status and gut microbiota. ✅
Go to Publication ✅
Animal nutrition (Zhongguo xu mu shou yi xue hui) (Anim Nutr ) Vol: 12 Issue Pages: 116-127 Pub: 2023 Mar Epub: 2022 Oct 1 Authors Jiang Z , Su W , Li W , Wen C , Du S , He H , Zhang Y , Gong T , Wang X , Wang Y , Jin M , Lu Z , |
|
|
The Effects of Dietary Bacillus amyloliquefaciens TL106 Supplementation, as an Alternative to Antibiotics, on Growth Performance, Intestinal Immunity, Epithelial Barrier Integrity, and Intestinal Microbiota in Broilers. ✅
Go to Publication ✅
Animals : an open access journal from MDPI (Animals (Basel) ) Vol: 12 Issue 22 Pages: Pub: 2022 Nov 9 Epub: 2022 Nov 9 Authors Bao C , Zhang W , Wang J , Liu Y , Cao H , Li F , Liu S , Shang Z , Cao Y , Dong B , |
|
|
Bacillus amyloliquefaciens SC06 in the diet improves egg quality of hens by altering intestinal microbiota and the effect is diminished by antimicrobial peptide. ✅
Go to Publication ✅
Frontiers in nutrition (Front Nutr ) Vol: 9 Issue Pages: 999998 Pub: 2022 Epub: 2022 Nov 1 Authors Xu S , Wang F , Zou P , Li X , Jin Q , Wang Q , Wang B , Zhou Y , Tang L , Yu D , Li W , |
|
|
Bacillus amyloliquefaciens SC06 alleviates the obesity of ob/ob mice and improves their intestinal microbiota and bile acid metabolism. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 13 Issue 9 Pages: 5381-5395 Pub: 2022 May 10 Epub: 2022 May 10 Authors Zeng Z , Zhou Y , Xu Y , Wang S , Wang B , Zeng Z , Wang Q , Ye X , Jin L , Yue M , Tang L , Zou P , Zhao P , Li W , |
|
|
Bacillus amyloliquefaciens SC06 alleviates the obesity of ob/ob mice and improves their intestinal microbiota and bile acid metabolism. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 13 Issue 9 Pages: 5381-5395 Pub: 2022 May 10 Epub: 2022 May 10 Authors Zeng Z , Zhou Y , Xu Y , Wang S , Wang B , Zeng Z , Wang Q , Ye X , Jin L , Yue M , Tang L , Zou P , Zhao P , Li W , |
|
|
Bacillus amyloliquefaciens TL106 protects mice against enterohaemorrhagic Escherichia coli O157:H7-induced intestinal disease through improving immune response, intestinal barrier function and gut microbiota. ✅
Go to Publication ✅
Journal of applied microbiology (J Appl Microbiol ) Vol: 131 Issue 1 Pages: 470-484 Pub: 2021 Jul Epub: 2020 Dec 18 Authors Bao CL , Liu SZ , Shang ZD , Liu YJ , Wang J , Zhang WX , Dong B , Cao YH , |
|
|
Inclusion of Bacillus amyloliquefaciens strain TOA5001 in the diet of broilers suppresses the symptoms of coccidiosis by modulating intestinal microbiota. ✅
Go to Publication ✅
Animal science journal = Nihon chikusan Gakkaiho (Anim Sci J ) Vol: 89 Issue 4 Pages: 679-687 Pub: 2018 Apr Epub: 2017 Dec 28 Authors Tsukahara T , Inoue R , Nakayama K , Inatomi T , |
|
|
Inclusion of Bacillus amyloliquefaciens strain TOA5001 in the diet of broilers suppresses the symptoms of coccidiosis by modulating intestinal microbiota. ✅
Go to Publication ✅
Animal science journal = Nihon chikusan Gakkaiho (Anim Sci J ) Vol: 89 Issue 4 Pages: 679-687 Pub: 2018 Apr Epub: 2017 Dec 28 Authors Tsukahara T , Inoue R , Nakayama K , Inatomi T , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
